Skip to Content


UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Calcium channel blocker

Chemical Name

3,-5-Pyridinedicarboxilic acid,4-[2-[3-(1,1-dimetyletoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimetyl-,dietyl ester, (E)-

Foreign Names

  • Lacidipinum (Latin)
  • Lacidipin (German)
  • Lacidipine (French)
  • Lacidipino (Spanish)

Generic Names

  • Lacidipina (OS: DCIT)
  • Lacidipine (OS: USAN, DCF, BAN)
  • GR 43659 X (IS: Glaxo)
  • GX 1048 (IS: Glaxo)
  • Lacidipine (PH: BP 2016)

Brand Names

  • Aponil
    Glaxo Allen, Italy
  • Caldine
    Boehringer Ingelheim, France
  • Lacibloc
    Ultramed, Philippines
  • Lacicard
    Aristopharma, Bangladesh
  • Lacidac
    Delta Pharma, Egypt
  • Lacidip
    Incepta, Bangladesh
  • Lacidipin Teva
    Teva, Denmark; Teva, Lithuania
  • Lacidipina Generis
    Generis, Portugal
  • Lacidipina Teva
    Teva Italia, Italy
  • Lacidipine Teva
    Teva, Netherlands; Teva Eesti, Estonia; Teva Pharmaceuticals, Poland
  • Lacidipino Teva
    Teva, Spain
  • Lacimen
    GlaxoSmithKline, Spain
  • Lacipil
    BB Farma, Italy; Glaxo Wellcome, Portugal; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Brazil; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Estonia; GlaxoSmithKline, Egypt; GlaxoSmithKline, Spain; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Vietnam; GSK, Turkey; Programmi Sanitari int., Italy; Wellcome Limited, Bosnia & Herzegowina
  • Lacipin
    RAK, Bangladesh
  • Lacirex
    Laboratori Guidotti, Italy
  • Lacitab
    Acme, Bangladesh
  • Laciten
    Square, Bangladesh
  • Lacitens
    GlaxoSmithKline, Greece
  • Lacydyna
    Rivopharm, Poland
  • Ladip
    Glaxo Allen, Italy; GlaxoSmithKline, Croatia (Hrvatska)
  • Lanidiem
    Samil, South Korea
  • Lapixen
    Biofarm, Poland
  • Lasyn
    Synmosa, Taiwan
  • L-Cardin
    Drug International, Bangladesh
  • Lodipine
    Egyphar, Egypt
  • Monopin
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska)
  • Motens
    Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim España, Spain; GlaxoSmithKline UK, United Kingdom
  • Sinopil
    GlaxoSmithKline, India
  • Tens
    Unilfarma, Portugal
  • Viapres
    Crinos, Italy


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.